These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7907849)

  • 1. Assessment of proliferating cell nuclear antigen (PCNA) immunoreactivity in exocrine pancreatic carcinomas.
    Seki H; Konstantinidou AE; Papaevangelou M; Apostolikas N; Parassi E; Koyama K; Lygidakis N
    Anticancer Res; 1993; 13(6B):2393-7. PubMed ID: 7907849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of proliferating cell nuclear antigen (PCNA) immunoreactivity in exocrine pancreatic carcinomas.
    Iachino C; Katsikoyiannis N; Dallera F
    Pathologica; 1995 Feb; 87(1):56-8. PubMed ID: 7567167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF
    Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA).
    Ramael M; Jacobs W; Weyler J; Van Meerbeeck J; Białasiewicz P; Van den Bossche J; Buysse C; Vermeire P; Van Marck E
    J Pathol; 1994 Mar; 172(3):247-53. PubMed ID: 7910850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.
    Hall PA; Levison DA; Woods AL; Yu CC; Kellock DB; Watkins JA; Barnes DM; Gillett CE; Camplejohn R; Dover R
    J Pathol; 1990 Dec; 162(4):285-94. PubMed ID: 1981239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay in fixation does not affect the immunoreactivity of proliferating cell nuclear antigen (PCNA).
    Start RD; Cross SS; Clelland C; Silcocks PB; Rogers K; Smith JH
    J Pathol; 1992 Oct; 168(2):197-9. PubMed ID: 1361001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of p53 expression and proliferative activity in gastric cancer.
    Yonemura Y; Fushida S; Tsugawa K; Ninomiya I; Fonseca L; Yamaguchi A; Miyazaki I; Urano T; Shiku H
    Anal Cell Pathol; 1993 Sep; 5(5):277-88. PubMed ID: 8105878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
    Li N
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferative activity.
    Ioachim E; Goussia A; Stefanou D; Agnantis NJ
    Anticancer Res; 1997; 17(1A):513-7. PubMed ID: 9066704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
    Kram A; Domagała W
    Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of proliferating cell nuclear antigen (PCNA) in dysplasia of the bronchial epithelium.
    Pendleton N; Dixon GR; Burnett HE; Occleston NL; Myskow MW; Green JA
    J Pathol; 1993 Jun; 170(2):169-72. PubMed ID: 8102179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
    Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
    Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus.
    Dabrowski A; Szumiło J; Brajerski G; Wallner G
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():59-67. PubMed ID: 11977365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.